PDSB - PDS Biotechnology Corporation (PDSB) CEO Frank Bedu-Addo on Q4 2020 Results - Earnings Call Transcript

PDS Biotechnology Corporation (PDSB) Q4 2020 Earnings Conference Call March 18, 2021 08:00 A.M. ET Company Participants Deanne Randolph - IR Frank Bedu-Addo - CEO Lauren V. Wood - CMO Seth L. Van Voorhees - CFO Conference Call Participants Joseph Pantginis - H.C. Wainwright & Company Trevor Allred - Oppenheimer & Company Presentation Operator Greetings and welcome to the PDS Biotechnology's Fourth Quarter and Fiscal Year 2020 Earnings Call and Webcast. [Operator Instructions]. A question-and-answer session will follow the formal presentation. As a reminder this conference is being recorded. It is now my pleasure to turn the call over to Deanne Randolph, Investor Relations for PDS Biotechnology. Please go ahead Deanne. Deanne Randolph Good morning and welcome to PDS Biotechnology's fourth quarter and full year 2020 earnings conference call and audio webcast. With me today are Dr. Frank Bedu-Addo, Chief Executive Officer; Dr. Lauren V. Wood, Chief Medical Officer; and

For further details see:

PDS Biotechnology Corporation (PDSB) CEO Frank Bedu-Addo on Q4 2020 Results - Earnings Call Transcript